FDA Drugs recall ·
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit… recall
- Recall number
- D-0241-2026
- Date
- (initiated December 12, 2025)
- Company / brand
- Merck Sharp & Dohme LLC
4633 Merck Rd W, Wilson, NC, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 3 - single dose kits
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Why was it recalled?
Presence of particulate matter: potential presence of metal particulates in the product.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot #: Z014503, Exp 11/15/2027
Distribution
Nationwide in the USA
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0241-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.